Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current controversies in the treatment of HIV infection and AIDS. An economic perspective.

Literature DB >> 10163412

Current controversies in the treatment of HIV infection and AIDS. An economic perspective.

S Petrou¹.

Abstract

Entities: Disease

Mesh：

Year: 1996 PMID： 10163412 DOI： 10.2165/00019053-199610020-00001

Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981

× No keyword cloud information.

15 in total

1. Early versus late treatment with zidovudine.

Authors: A De Maria
Journal: N Engl J Med Date: 1992-07-30 Impact factor: 91.245

2. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.

Authors: J P Aboulker; A M Swart
Journal: Lancet Date: 1993-04-03 Impact factor: 79.321

3. Hospital cost for patients with HIV infection in a university hospital in The Netherlands.

Authors: J C Borleffs; J C Jager; M J Poos; M G Dijkgraaf; R M Geels; H Vrehen; A J Schrijvers
Journal: Health Policy Date: 1990 Impact factor: 2.980

Review 4. Defining and measuring the costs of the HIV epidemic to business firms.

Authors: P G Farnham
Journal: Public Health Rep Date: 1994 May-Jun Impact factor: 2.792

5. A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group.

Authors: J O Kahn; S W Lagakos; D D Richman; A Cross; C Pettinelli; S H Liou; M Brown; P A Volberding; C S Crumpacker; G Beall
Journal: N Engl J Med Date: 1992-08-27 Impact factor: 91.245

6. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Authors: E M Connor; R S Sperling; R Gelber; P Kiselev; G Scott; M J O'Sullivan; R VanDyke; M Bey; W Shearer; R L Jacobson
Journal: N Engl J Med Date: 1994-11-03 Impact factor: 91.245

7. Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.

Authors: M A Fischl; K Stanley; A C Collier; J M Arduino; D S Stein; J E Feinberg; J D Allan; J C Goldsmith; W G Powderly
Journal: Ann Intern Med Date: 1995-01-01 Impact factor: 25.391

8. Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.

Authors: S L Spruance; A T Pavia; D Peterson; A Berry; R Pollard; T F Patterson; I Frank; S C Remick; M Thompson; R D MacArthur; G E Morey; C H Ramirez-Ronda; B M Bernstein; D E Sweet; L Crane; E A Peterson; C T Pachucki; S L Green; J Brand; A Rios; L M Dunkle; A Cross; M J Brown; P Ingraham; R Gugliotti; A H Schindzielorz; L Smaldone
Journal: Ann Intern Med Date: 1994-03-01 Impact factor: 25.391

9. AIDS treatment costs during the last months of life: evidence from the ACSUS.

Authors: F J Hellinger; J A Fleishman; D C Hsia
Journal: Health Serv Res Date: 1994-12 Impact factor: 3.402

10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors: P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal: N Engl J Med Date: 1990-04-05 Impact factor: 91.245

4 in total